-
AbbVie Inc. (ABBV $228.72)
-
Danaher Corporation (DHR $208.56)
-
Eli Lilly and Company (LLY $1,020.56)
-
Thermo Fisher Scientific Inc (TMO $513.56)
-
Lantheus Holdings Inc. (LNTH $73.06)
Q: As I'm sure you're aware, this is a name that has been drifting steadily lower since it ranked on its disappointing latest earnings release. Do you think it remains a premier us drug manufacturer worth holding or would you recommend redeploying the capital into another name?